Mesenchymal Stem Cells
37
3
4
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.7%
1 terminated out of 37 trials
90.0%
+3.5% vs benchmark
3%
1 trials in Phase 3/4
11%
1 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (37)
Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT
Expanded Access Multi-Patient Experimental Treatment Involving Allogeneic Human Mesenchymal Stem Cells (hMSCs) in Subjects With Acute Ischemic Stroke (EXPAND)
Study of Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in Vitiligo
Muscle Stem Cell Quality in Atrophy
Treatment With Human Umbilical Cord-derived Mesenchymal Stromal Cells in Systemic Sclerosis
Mesenchymal Stromal Cells in Living Donor Kidney Transplantation
Study of Human Umbilical Cord-derived Mesenchymal Stem Cells for Treatment of Refractory Immune Thrombocytopenia
HUC-MSC for Treatment of High-risk HPV Infection
Evaluate the Safety and Feasibility of Allogeneic Mesenchymal Stem Cells in Patients With Multiple Sclerosis
Treatment of Oral Chronic Graft-versus-host Disease With Human Umbilical Cord Mesenchymal Stem Cell Dressing
Open Label Single Arm Proof of Concept Trial to Evaluate the Efficacy and Safety of Cytori Celution System in Diabetic Leg Ulcers
Open Label Single Arm Proof of Concept Trial to Evaluate the Efficacy and Safety of Cytori Celution System in Chronic Non-Healing Venous Leg Ulcers
Clinical Trial of Mesenchymal Stem Cells in the Treatment of Severe Acute Kidney Injury
Treatment of Oral Mucositis Using Platelet Rich Fibrin TREATMENT OF ORAL MUCOSITIS USING PRF
Cell Therapy With Cellistem-OA for Symptomatic Knee Osteoarthritis
Umbilical Cord Mesenchymal Stem Cells Therapy for Diabetic Nephropathy
Mesenchymal Stem Cells to Treat Type 2 Diabetes
Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth
Mesenchymal Stem Cells for Radiation-induced Xerostomia
Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cells Transplantation in Patients With Type 2 Diabetes Mellitus